Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11918563 Methods and compositions for treatment of epileptic disorders

Patent 11918563 was granted and assigned to Ovid Therapeutics on March, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Ovid Therapeutics

Current Assignee

Ovid Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119185630

Patent Inventor Names

Matthew During0

Date of Patent

March 5, 2024

Patent Application Number

184941550

Date Filed

October 25, 2023

Patent Citations

‌

US Patent 7078057 Process for producing nanometer particles by fluid bed spray-drying

‌

US Patent 7198795 None

‌

US Patent 7550445 Aripiprazole complex formulation and method

‌

US Patent 7858609 Solid ganaxolone formulations and methods for the making and use thereof

‌

US Patent 8022054 Liquid ganaxolone formulations and methods for the making and use thereof

‌

US Patent 8318714 Liquid ganaxolone formulations and methods for the making and use thereof

‌

US Patent 8362286 Method for making 3α-hydroxy, 3β- substituted-5α-pregnan-20-ones

‌

US Patent 8367651 Solid ganaxolone formulations and methods for the making and use thereof

...

Patent Primary Examiner

CPC Code

Patent abstract

Use of allosteric modulators and/or gaboxadol for the treatment of epileptic disorders in a subject in need thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11918563 Methods and compositions for treatment of epileptic disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API